What changed: Extensive-stage small-cell lung cancer
Every dated change on the records linked to Extensive-stage small-cell lung cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
September 2026 · 1
2026 · 3
- 2026ApprovalLurbinectedinLurbinectedin approved in EU
Maintenance with atezolizumab in ES-SCLC after first-line induction; 29 May 2026
- 2026ApprovalTarlatamabTarlatamab approved in EU
ES-SCLC after platinum-based chemotherapy; 29 May 2026
- 2026Trial resultDeLLphi-305DeLLphi-305 reported
Met the primary overall survival endpoint at the pre-specified interim analysis (Amgen, 8 September 2026); progression-free survival and response rate also improved; figures not yet disclosed.
February 2025 · 1
2025 · 5
- 2025ApprovalLurbinectedinLurbinectedin approved in US
First-line maintenance with atezolizumab in ES-SCLC (full approval)
- 2025ApprovalSerplulimabSerplulimab approved in EU
First-line ES-SCLC with carboplatin-etoposide
- 2025Trial resultDeLLphi-304DeLLphi-304 reported
OS HR 0.
- 2025Trial resultIMforteIMforte reported
OS 13.
- 2025MilestoneDeLLphi-304DeLLphi-304: tarlatamab lengthens survival after relapse; IMforte: lurbinectedin maintenance approved
A milestone in how this cancer is treated.
May 2024 · 1
2024 · 2
November 2022 · 1
2022 · 3
2020 · 1
2019 · 2
2018 · 2
2017 · 2
- 2017Trial resultTakahashi trial: prophylactic cranial irradiation with MRI surveillance in extensive-stage small-cell lung cancerTakahashi trial: prophylactic cranial irradiation with MRI surveillance in extensive-stage small-cell lung cancer reported
Median overall survival 11.
- 2017MilestoneTakahashi trial: prophylactic cranial irradiation with MRI surveillance in extensive-stage small-cell lung cancerTakahashi: no survival benefit from prophylactic cranial irradiation with MRI surveillance
A milestone in how this cancer is treated.
2007 · 2
- 2007Trial resultEORTC 08993 (Slotman): prophylactic cranial irradiation in extensive-stage small-cell lung cancerEORTC 08993 (Slotman): prophylactic cranial irradiation in extensive-stage small-cell lung cancer reported
Symptomatic brain metastases at 1 year 14.
- 2007MilestoneEORTC 08993 (Slotman): prophylactic cranial irradiation in extensive-stage small-cell lung cancerSlotman: prophylactic cranial irradiation improves survival in extensive stage when brain imaging is not routine
A milestone in how this cancer is treated.